#jcdd #RecommendedPaper Title: Cardiotoxicity of Non-Anthracycline Cancer Chemotherapy Agents Keywords: cardiotoxicity; cardiac dysfunction; non-anthracycline agents; chemotherapy; immunotherapy; cardioprotection The aim of this narrative review is to demonstrate new knowledge regarding the screening and diagnosis of non-anthracycline-induced cardiotoxicity and to propose protective measures that could be performed in order to achieve the delivery of optimal care. 👉Read more at: https://brnw.ch/21wLgnR
JCDD MDPI’s Post
More Relevant Posts
-
In patients with locally advanced colon cancer, prophylactic HIPEC in addition to surgical resection and adjuvant systemic chemotherapy seems to significantly improve the locoregional recurrence rate in high-risk subgroups. #COLOPEC and #HIPECT4 trials. #hospitalreinasofia #annalsofoncology #esmoGI #ESMO #aecirujanos https://lnkd.in/dfrqyvNG
To view or add a comment, sign in
-
Paper Alert: Oral Dexamethasone Enhances Efficacy of Docetaxel-Ramucirumab Therapy in Previously Treated Lung Cancer: A Retrospective Analysis Sage https://lnkd.in/etCc-KDF #Cancer #Docetaxel #LungCancer #OncoDaily #Oncology #Medicine #Health #OralDexamethasone #Ramucirumab #SageJournals
To view or add a comment, sign in
-
🎖Check out the Highly cited #Article "Approaches to the Management of Metastatic Adenoid Cystic Carcinoma" 👏by Rex Lee et al. University of California, San Francisco Find out more here▶️ https://lnkd.in/dZmpt9Wn Keywords: adenoid cystic carcinoma (ACC); salivary gland cancer; metastasis; systemic therapy; chemotherapy; tyrosine kinase inhibitor (TKI); immunotherapy; metastasectomy; radiation; SBRT
To view or add a comment, sign in
-
A recent study presents a predictive model for recurrence in colorectal peritoneal metastases patients undergoing CRS-HIPEC. Significant predictors include peritoneal cancer index (PCI) and primary tumor location, demonstrating fair discrimination (C-index 0.64). With a 78% recurrence rate observed in 408 patients, this tool aids in identifying high-risk patients who may benefit from adjunctive systemic therapy, potentially improving survival outcomes. Further external validation and research are necessary to enhance patient selection and treatment strategies. #ColorectalCancer #CRS #HIPEC #OncologyResearch #PredictiveModeling
To view or add a comment, sign in
-
Understanding Long-Term Effects of Radiation Treatment for Prostate Cancer: Radiation therapy is effective for treating prostate cancer but may have long-term effects like urinary issues, bowel problems, and erectile dysfunction. With any kind of treatment it is important to discuss potential side effects with your healthcare provider. Using #theranostics to treat prostate cancer has mild side effects like dry mouth and light fatigue. #ProstateCancer #RadiationTherapy #HealthAwareness #Cancer #EraseCancer
To view or add a comment, sign in
-
New multicentre study reveals that adjuvant chemotherapy following pancreatic resection for adenocarcinoma from IPMN is not associated with improved recurrence or survival rates, even in high-risk subgroups. This challenges current approaches and underscores the need for alternative strategies in pancreatic cancer treatment. #CancerResearch #ClinicalOncology
To view or add a comment, sign in
-
Executive Editor - Gold Open Access Journals & Technology in Cancer Research & Treatment (IF 2.7; CiteScore 4.4). PhD in Molecular, Cell & Developmental Biology, UCLA.
Check out this great summary of an article published in Technology in Cancer Research & Treatment's sister journal, Cancer Control. Link in the post below. George Vlachogiannis Sage #oncology #lungcancer #cancertreatment
Paper Alert: Oral Dexamethasone Enhances Efficacy of Docetaxel-Ramucirumab Therapy in Previously Treated Lung Cancer: A Retrospective Analysis Sage https://lnkd.in/etCc-KDF #Cancer #Docetaxel #LungCancer #OncoDaily #Oncology #Medicine #Health #OralDexamethasone #Ramucirumab #SageJournals
To view or add a comment, sign in
-
🔬 With early-onset #coloncancer rates rising steadily since the mid-1990s, deciding how to optimally treat patients presents some challenges. 👉 Learn how a recent study investigated the differing administration rates of adjuvant chemotherapy in patients with early- and late-onset stage 2 colon cancer to determine the best course of treatment to maximize outcomes:
Adjuvant Chemotherapy in Colon Cancer: Younger Patients at Higher Risk of Adverse Events | Docwire News
docwirenews.com
To view or add a comment, sign in
-
Newer molecular technologies and bioinformatic platforms appear to have helped give rise to enhanced cell therapies with more positive results, thanks to the improved design of chimeric antigen receptors, upregulated specificity and perhaps down-regulation of off-tumour activity
📣 Want to know more about CAR-T cells ? What are CAR-T cells, what are CAR variants and what are the cancers they been approved for use ? Join the #knowmics interactive Webinar session: *CAR-T Cell Therapy Explained* by Dr. Sourabh Radhakrishnan , Director Medical and Precision Oncology Karkinos Healthcare 📅 Saturday, 11th May 2024 🕒 8.00 PM to 9.00 PM ( IST ) Register Now: https://lnkd.in/gX-3UzPS #CART #Oncology #PrecisionMedicine #GeneTherapy #Cancer #India #PublicHealth
To view or add a comment, sign in
77 followers